GlassScriptPhysician profile
Ashley Dawn Fitzpatrick
NPI 1265831341
$944.19
in general payments reported to CMS, 2019-2025
16 companies · $252 in 2025
The $252 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $91.17 · 2022: $220 · 2023: $145 · 2024: $236 · 2025: $252.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $633.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $632.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $343.16 | 2022-2025 | |
| Amgen INC. | $124.34 | 2021-2025 | Evenity, Prolia, Otezla |
| Janssen Pharmaceuticals, INC | $107.37 | 2021-2023 | Xarelto |
| Glaxosmithkline, LLC. | $98.70 | 2021-2024 | Trelegy Ellipta, Arexvy, Shingrix |
| Novo Nordisk INC | $51.30 | 2024-2025 | Rybelsus, Wegovy |
| Abbott Laboratories | $40.19 | 2025 | Mitraclip, Triclip |
| Paratek Pharmaceuticals, INC. | $23.41 | 2023 | Nuzyra |
| Vertex Pharmaceuticals Incorporated | $22.97 | 2025 | |
| Exact Sciences Corporation | $22.61 | 2025 | Cologuard Collection Kit |
| Biohaven Pharmaceutical Holding Company LTD. | $22.24 | 2022 | |
| Dexcom, INC. | $18.94 | 2024 | Dexcom G6 Transmitter |
| Organon LLC | $18.45 | 2024 | |
| Novartis Pharmaceuticals Corporation | $17.42 | 2024 | |
| Astrazeneca Pharmaceuticals LP | $16.18 | 2025 | Airsupra |
| Bardy Diagnostics, INC. | $14.10 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $2.81 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashley Fitzpatrick listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.